Spectris PLC CHAIRMAN TO TAKE MEDICAL LEAVE OF ABSENCE (6598D)
April 28 2017 - 3:11AM
UK Regulatory
TIDMSXS
RNS Number : 6598D
Spectris PLC
28 April 2017
Spectris plc
CHAIRMAN TO TAKE MEDICAL LEAVE OF ABSENCE
28 April 2017 - The Board of Spectris plc ('Spectris') (LSE:
SXS), the productivity-enhancing instrumentation and controls
company, announces that Dr John Hughes, non-executive Chairman, has
taken leave of absence in order to undergo medical treatment.
Russell King, Senior Independent Director, will assume the Chair
until John's return or the appointment of his successor on
completion of the recruitment process which was announced on 5
December 2016.
- ENDS -
Contacts:
Spectris plc
Siobhán Andrews,
Head of Corporate Affairs +44 1784 470470
FTI Consulting
Richard Mountain/Susanne
Yule +44 203 727 1340
ABOUT SPECTRIS
Spectris plc is a leading supplier of productivity-enhancing
instrumentation and controls. The Company's products and
technologies help customers to improve product quality and
performance, improve core manufacturing processes, reduce downtime
and wastage and reduce time to market. Its global customer base
spans a diverse range of end user markets. Spectris operates across
four business segments which reflect the applications and
industries it serves: Materials Analysis, Test and Measurement,
In-line Instrumentation and Industrial Controls. Headquartered in
Egham, Surrey, United Kingdom, the Company employs around 8,900
people with offices in more than 30 countries. For more
information, visit www.spectris.com (http://www.spectris.com).
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSEWSWAFWSESL
(END) Dow Jones Newswires
April 28, 2017 03:11 ET (07:11 GMT)
Spectris (LSE:SXS)
Historical Stock Chart
From May 2024 to Jun 2024
Spectris (LSE:SXS)
Historical Stock Chart
From Jun 2023 to Jun 2024